Esketamine nasal and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Esketamine nasal and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: esketamine
Brand name: Spravato
Synonyms: Esketamine (nasal), Esketamine
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Esketamine nasal-Insulin degludec
- Esketamine nasal-Insulin Degludec (U-100) Prefilled Pens
- Esketamine nasal-Insulin Degludec (U-100) Vials
- Esketamine nasal-Insulin Degludec (U-200) Prefilled Pens
- Esketamine nasal-Insulin degludec and liraglutide
- Esketamine nasal-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Eslicarbazepine
- Insulin aspart, recombinant Subcutaneous-Eslicarbazepine Acetate
- Insulin aspart, recombinant Subcutaneous-Esmolol
- Insulin aspart, recombinant Subcutaneous-Esmolol HCl
- Insulin aspart, recombinant Subcutaneous-Esmolol Hydrochloride
- Insulin aspart, recombinant Subcutaneous-Esmolol Injection